Improving medication management to reduce dementia risk in African Americans and Latinos

Enhanced Medication Management to Control ADRD Risk Factors Among African Americans and Latinos

['FUNDING_SBIR_1'] · PILLTRAX SYSTEMS LLC · NIH-10610975

This study is all about helping African Americans and Latinos take their medications regularly to better manage conditions like high blood pressure and diabetes, which can lower the risk of developing Alzheimer's disease and related dementias, using tools like a smart pill dispenser and text reminders.

Quick facts

Phase['FUNDING_SBIR_1']
Study typeNih_funding
SexAll
SponsorPILLTRAX SYSTEMS LLC (nih funded)
Locations1 site (Brighton, UNITED STATES)
Trial IDNIH-10610975 on ClinicalTrials.gov

What this research studies

This research focuses on enhancing medication adherence among African Americans and Latinos to better manage risk factors for Alzheimer's disease and related dementias (ADRD). It aims to implement a medication management service that includes an electronic pill dispenser, SMS notifications for medication adherence, and a provider portal for tracking adherence data. By addressing the low adherence rates to hypertension and diabetes medications, the project seeks to lower the risk of developing ADRD in these populations. The approach is designed to be proactive and supportive, helping patients stay on track with their medications.

Who could benefit from this research

Good fit: Ideal candidates for this research are African American and Latino individuals who are at risk for Alzheimer's disease and related dementias due to hypertension or diabetes.

Not a fit: Patients who do not have hypertension or diabetes, or those who are not part of the African American or Latino communities may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could significantly reduce the risk of Alzheimer's disease and related dementias among African Americans and Latinos.

How similar studies have performed: Previous research has shown that improving medication adherence can lead to better health outcomes, indicating that this approach has potential for success.

Where this research is happening

Brighton, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Alzheimer disease dementia

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.